Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15,691 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Reprogramming anchorage dependency by adherent-to-suspension transition promotes metastatic dissemination.
Huh HD, Sub Y, Oh J, Kim YE, Lee JY, Kim HR, Lee S, Lee H, Pak S, Amos SE, Vahala D, Park JH, Shin JE, Park SY, Kim HS, Roh YH, Lee HW, Guan KL, Choi YS, Jeong J, Choi J, Roe JS, Gee HY, Park HW. Huh HD, et al. Among authors: kim hr, kim hs, kim ye. Mol Cancer. 2023 Mar 30;22(1):63. doi: 10.1186/s12943-023-01753-7. Mol Cancer. 2023. PMID: 36991428 Free PMC article.
Correction: Reprogramming anchorage dependency by adherent‑to‑suspension transition promotes metastatic dissemination.
Huh HD, Sub Y, Oh J, Kim YE, Lee JY, Kim HR, Lee S, Lee H, Pak S, Amos SE, Vahala D, Park JH, Shin JE, Park SY, Kim HS, Roh YH, Lee HW, Guan KL, Choi YS, Jeong J, Choi J, Roe JS, Gee HY, Park HW. Huh HD, et al. Among authors: kim hr, kim hs, kim ye. Mol Cancer. 2023 Aug 14;22(1):135. doi: 10.1186/s12943-023-01838-3. Mol Cancer. 2023. PMID: 37580748 Free PMC article. No abstract available.
Clinical Practice Recommendations for the Use of Next-Generation Sequencing in Patients with Solid Cancer: A Joint Report from KSMO and KSP.
Kim M, Shim HS, Kim S, Lee IH, Kim J, Yoon S, Kim HD, Park I, Jeong JH, Yoo C, Cheon J, Kim IH, Lee J, Hong SH, Park S, Jung HA, Kim JW, Kim HJ, Cha Y, Lim SM, Kim HS, Lee CK, Kim JH, Chun SH, Yun J, Park SY, Lee HS, Cho YM, Nam SJ, Na K, Yoon SO, Lee A, Jang KT, Yun H, Lee S, Kim JH, Kim WS. Kim M, et al. Among authors: kim ih, kim hj, kim s, kim j, kim hs, kim hd, kim ws, kim jw, kim jh. Cancer Res Treat. 2023 Nov 29. doi: 10.4143/crt.2023.1043. Online ahead of print. Cancer Res Treat. 2023. PMID: 38037319 Free article.
Mouse-human co-clinical trials demonstrate superior anti-tumour effects of buparlisib (BKM120) and cetuximab combination in squamous cell carcinoma of head and neck.
Kim HR, Kang HN, Yun MR, Ju KY, Choi JW, Jung DM, Pyo KH, Hong MH, Ahn MJ, Sun JM, Kim HS, Kim J, Yoo J, Kim KR, Koh YW, Kim SH, Choi EC, Yoon SO, Shim HS, Paik S, Kim TM, Cho BC. Kim HR, et al. Among authors: kim sh, kim kr, kim tm, kim hs, kim j. Br J Cancer. 2020 Dec;123(12):1720-1729. doi: 10.1038/s41416-020-01074-2. Epub 2020 Sep 23. Br J Cancer. 2020. PMID: 32963347 Free PMC article. Clinical Trial.
Hepatic arterial infusion in combination with systemic chemotherapy in patients with hepatic metastasis from colorectal cancer: a randomized phase II study - (NCT05103020) - study protocol.
Kim JS, Kim H, Lee SY, Han YD, Han K, Min BS, Kim MD, Won JY, Beom SH, Shin SJ, Kim HS, Han DH, Ahn JB. Kim JS, et al. Among authors: kim h, kim md, kim hs. BMC Cancer. 2023 Jul 22;23(1):691. doi: 10.1186/s12885-023-11085-w. BMC Cancer. 2023. PMID: 37481515 Free PMC article.
Development and validation of a prognostic model for patients with hepatocellular carcinoma undergoing radiofrequency ablation.
Kim CG, Lee HW, Choi HJ, Lee JI, Lee HW, Kim SU, Park JY, Kim DY, Ahn SH, Han KH, Kim HS, Kim KH, Choi SJ, Kim Y, Lee KS, Kim GM, Kim MD, Won JY, Lee DY, Kim BK. Kim CG, et al. Among authors: kim su, kim dy, kim gm, kim md, kim bk, kim hs, kim y, kim kh. Cancer Med. 2019 Sep;8(11):5023-5032. doi: 10.1002/cam4.2417. Epub 2019 Jul 10. Cancer Med. 2019. PMID: 31290618 Free PMC article.
15,691 results
You have reached the last available page of results. Please see the User Guide for more information.